Corrigendum: Randomized, Double Blind, Placebo Controlled, Clinical Trial to Study Ashwagandha Administration in Participants Vaccinated Against COVID-19 on Safety, Immunogenicity, and Protection With COVID-19 Vaccine–A Study Protocol

• Arvind Chopra,
• Preeti Chavan-Gautam,
• Girish Tillu,
• Manjit Saluja,
• Swapnil Borse,
• Sanjeev Sarmukaddam,
• Susmita Chaudhuri,
• BCS Rao,
• Babita Yadav,
• Narayanam Srikanth,
• Bhushan Patwardhan

Affiliations

Arvind Chopra

Center for Rheumatic Diseases, Pune, India

Preeti Chavan-Gautam

Center for Complementary and Integrative Health, Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India

Girish Tillu

Center for Complementary and Integrative Health, Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India

Manjit Saluja

Center for Rheumatic Diseases, Pune, India

Swapnil Borse

Center for Complementary and Integrative Health, Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India

Sanjeev Sarmukaddam

Center for Rheumatic Diseases, Pune, India

Susmita Chaudhuri

Translational Health Science and Technology Institute (THSTI), Faridabad, India

BCS Rao

Central Council for Research in Ayurvedic Science, New Delhi, India

Babita Yadav

Central Council for Research in Ayurvedic Science, New Delhi, India

Narayanam Srikanth

Central Council for Research in Ayurvedic Science, New Delhi, India

Bhushan Patwardhan

Center for Complementary and Integrative Health, Interdisciplinary School of Health Sciences, Savitribai Phule Pune University, Pune, India